Open Save New
FeedNavigator / National Library of Health Sciences
 
  
Tutkijat / Oulu
AddAla-Kokko, L.
AddAla-Kokko, T(ero)
AddAla-Korpela, M(ika)
AddAlahuhta, S.
AddAlén, M(arkku)
AddAntikainen, R.
AddAnttonen, V(uokko)
AddBiancari, F(austo)
AddBloigu, R(isto)
AddEskelinen, S.
AddFlinkkilä, T(apio)
AddHakkola, J.
AddHallman, M.
AddHartikainen, A(nna)-L(iisa)
AddHausen, H.
AddHautala, N(ina)
AddHautala, T(imo)
AddHeape, A.
AddHerzig, K(arl)-H(einz)
AddHillbom, M.
AddHiltunen, J.K.
AddHörkko, S.
AddHuikuri, H(eikki)
AddHukkanen J(anne)
AddIgnatius, J.
AddIsohanni, M.
AddJaakkola, J.
AddJaakkola, M(aritta) S.
AddJaakola, V-P.
AddJämsä, T(imo)
AddJanhonen, S.
AddJartti, T(uomas)
AddJärvelin, M(arjo)-R(iitta)
AddJokelainen, J(ari)
AddJuffer, A.H.
AddJunttila, J(uhani)
AddJuvonen, T.
AddKaarteenaho, R(iitta)
AddKajantie, E(ero)*(THL/OY)
AddKarppinen (Koivunen), P(eppi)
AddKarppinen, J(aro)
AddKarttunen, T.J.
AddKeinänen-Kiukaanniemi, S(irkka)
AddKerkelä, R(isto)
AddKesäniemi, Y(rjö) A(ntero)
AddKettunen, J(ohannes)
AddKietzmann, T(homas).
AddKivirikko, K.I.
AddKnuuttila, M.
AddKoivukangas, J.
AddKursula, P.
AddKyngäs, H.
AddLarivaara, P.
AddLarmas, M.
AddLehenkari, P(etri)
AddLehtiö, L(ari)
AddLeppilahti, J.
AddLuukinen, H.
AddMainio A
AddMajamaa, K.
AddMäki, P(irjo)
AddMäkikallio, T(imo) H.
AddMännikkö, M(inna)
AddManninen, A(ki).
AddMartikainen, H(annu)
AddMiettunen, J(ouko)
AddMyllyharju, J.
AddMyllylä, R.
AddMyllylä, V.
AddNäyhä, S.
AddNeubauer, P.
AddNieminen, M(iika) T.
AddNieminen, P(entti)
AddNiinimäki, J(aakko)
AddOhukainen, P(auli)
AddOikarinen, A.
AddOikarinen, K.
AddPelkonen, O(lavi)
AddPetäjä-Repo, U.E.
AddPihlajaniemi, T.
AddPirttiniemi, P(ertti)
AddPuistola, U(lla)
AddRajaniemi, H.J.
AddRämet, M(ika)
AddRäsänen, P.
AddRaustia, A.
AddRemes, A(nne)
AddRisteli, J.
AddRistiniemi, J.
AddRuddock, L.W.
AddRuokonen, A.
AddRuskoaho, H.
AddRyynänen, M.
AddSaarakkala, S.
AddSaari, A.
AddSalo, T(uula)
AddSándor, G(eorge) K.
AddSavolainen, E-R.
AddSavolainen, M.J.
AddSavolainen, O.
AddSillanpää, M(ikko).
AddSoininen, R.
AddSorri, M.
AddTaanila, A.
AddTapiainen, T(erhi)
AddTervonen, O(smo)
AddTimonen, M(arkku)
AddTjäderhane, L.
AddTurpeenniemi-Hujanen, T.
AddTuukkanen, J(uha)
AddTuulonen, A.
AddUhari, M.
AddUkkola, O(lavi)
AddUusimaa, J.
AddVainio, O.
AddVainio, S.
AddVäyrynen, J(uha) P.
AddVeijola, J(uha)
AddVeijola, R(iitta)
AddVirokannas, H.
AddVoipio, H(anna)-M(arja)
AddVuolteenaho, O.
AddWeckström, M.
AddWei, GH.
AddWierenga, R.K.
AddWinqvist, R(obert)
AddYlänne, J.
AddYlitalo, K(ari)

Scholar Chart >>



»My Articles

»Latest Feeds

»Popular Feeds
Search Feed Catalog by Name:
Artificial intelligence identifies inflammation and confirms fibroblast foci as prognostic tissue biomarkers in idiopathic pulmonary fibrosis.Kaarteenaho, R(iitta)13 dayssaveRefWorks
Smoking-associated increase in mucins 1 and 4 in human airways.Kaarteenaho, R(iitta)64 dayssaveRefWorks
Bronchoalveolar lavage differential cell count on prognostic assessment of patients with stable or acute interstitial lung disease: A retrospective real-life study.Kaarteenaho, R(iitta)70 dayssaveRefWorks
The challenges in classifying rheumatoid arthritis-associated interstitial lung disease.Kaarteenaho, R(iitta)137 dayssaveRefWorks
Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases.Kaarteenaho, R(iitta)229 dayssaveRefWorks
'Compositional data analysis' by Barabesi and Sartorelli: Authors' response.Kaarteenaho, R(iitta)265 dayssaveRefWorks
A Family With A20 Haploinsufficiency Presenting With Novel Clinical Manifestations and Challenges for Treatment.Kaarteenaho, R(iitta)304 dayssaveRefWorks
Comparison of disease progression subgroups in idiopathic pulmonary fibrosis.Kaarteenaho, R(iitta)359 dayssaveRefWorks
Lats1 and Lats2 are required for the maintenance of multipotency in the Müllerian duct mesenchyme.Kaarteenaho, R(iitta)418 dayssaveRefWorks
Bronchoalveolar cell differential count and the number of asbestos bodies correlate with survival in patients with asbestosis.Kaarteenaho, R(iitta)488 dayssaveRefWorks
Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry.Kaarteenaho, R(iitta)497 dayssaveRefWorks
Inorganic particulate matter in the lung tissue of idiopathic pulmonary fibrosis patients reflects population density and fine particle levels.Kaarteenaho, R(iitta)561 dayssaveRefWorks
Cadherin-11-mediated adhesion of macrophages to myofibroblasts establishes a profibrotic niche of active TGF-β.Kaarteenaho, R(iitta)677 dayssaveRefWorks
Haploinsufficiency of A20 impairs protein-protein interactome and leads into caspase-8-dependent enhancement of NLRP3 inflammasome activation.Kaarteenaho, R(iitta)747 dayssaveRefWorks
Biallelic mutations in human NHLRC2 enhance myofibroblast differentiation in FINCA disease.Kaarteenaho, R(iitta)794 dayssaveRefWorks
Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: the case of two Nordic countries.Kaarteenaho, R(iitta)916 dayssaveRefWorks
The neutrophil-mobilizing cytokine interleukin-26 in the airways of long-term tobacco smokers.Kaarteenaho, R(iitta)917 dayssaveRefWorks
Underlying and immediate causes of death in patients with idiopathic pulmonary fibrosis.Kaarteenaho, R(iitta)926 dayssaveRefWorks
Analysis of the Histologic Features Associated With Interobserver Variation in Idiopathic Pulmonary Fibrosis.Kaarteenaho, R(iitta)1014 dayssaveRefWorks
NHLRC2 variants identified in patients with fibrosis, neurodegeneration, and cerebral angiomatosis (FINCA): characterisation of a novel cerebropulmonary disease.Kaarteenaho, R(iitta)1018 dayssaveRefWorks
Several high-resolution computed tomography findings associate with survival and clinical features in rheumatoid arthritis-associated interstitial lung disease.Kaarteenaho, R(iitta)1020 dayssaveRefWorks
Interleukin-26 Production in Human Primary Bronchial Epithelial Cells in Response to Viral Stimulation: Modulation by Th17 cytokines.Kaarteenaho, R(iitta)1181 dayssaveRefWorks
Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis.Kaarteenaho, R(iitta)1188 dayssaveRefWorks
Histological features of malignancy correlate with growth patterns and patient outcome in lung adenocarcinoma.Kaarteenaho, R(iitta)1321 dayssaveRefWorks
Are physicians in primary health care able to recognize pulmonary fibrosis?Kaarteenaho, R(iitta)1342 dayssaveRefWorks
Are risk predicting models useful for estimating survival of patients with rheumatoid arthritis-associated interstitial lung disease?Kaarteenaho, R(iitta)1409 dayssaveRefWorks
Gender differences in the T-cell profiles of the airways in COPD patients associated with clinical phenotypes.Kaarteenaho, R(iitta)1418 dayssaveRefWorks
Treatment of idiopathic pulmonary fibrosis: a position paper from a Nordic expert group.Kaarteenaho, R(iitta)1467 dayssaveRefWorks
Mucin-1 correlates with survival, smoking status, and growth patterns in lung adenocarcinoma.Kaarteenaho, R(iitta)1575 dayssaveRefWorks
Variable course of disease of rheumatoid arthritis-associated usual interstitial pneumonia compared to other subtypes.Kaarteenaho, R(iitta)1581 dayssaveRefWorks
Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD.Kaarteenaho, R(iitta)1637 dayssaveRefWorks
Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis.Kaarteenaho, R(iitta)1754 dayssaveRefWorks
 XML / RSS feed
report